Ledipasvir/Sofosbuvir for 12 or 24 Weeks Is Safe and Effective in Kidney Transplant Recipients with Chronic Genotype 1 or 4 Hcv Infection

Massimo Colombo, Alessio Aghemo, L. Liu, R. Hyland, D. Brainard, John G. McHutchison, Marc Bourlière, Markus Peck‐Radosavljevic, Michael P. Manns, Stanislas Pol

Journal of Hepatology · 2016 · 18 citations · 0 references

Concepts